Newsletter Signup | Join Community
Brukinsa is a novel BTK inhibitor with encouraging anti-cancer activity in the management of CLL/SLL.
ASH 2019 update report Calquence delays CLL progression compared to Gazyva + Chlorambucil
FDA Approves Venclexta, Daurismo, and Xospata Precision Cancer Medicines for Treatment of Acute Myeloid Leukemia
The 2nd generation TKI flumatinib appears to control CP-CML better than the historical standard of Gleevec.
Imbruvica® Rituxan combination superior to FCR chemotherapy for treatment of newly diagnosed CLL
Beth Israel Deaconess Medical Center doctors vaccine improves outcomes for patients suffering from AML
Quizartinib Improves Survival in Select Patients with Relapsed/Refractory Acute Myeloid Leukemia
considering CAR T for ALL - anyone been through it yet?
looking for others to share their experience with stem cell transplant for leukemia.